KR102221041B1 - 신증후군 및 관련 병태의 치료 방법 - Google Patents

신증후군 및 관련 병태의 치료 방법 Download PDF

Info

Publication number
KR102221041B1
KR102221041B1 KR1020157029360A KR20157029360A KR102221041B1 KR 102221041 B1 KR102221041 B1 KR 102221041B1 KR 1020157029360 A KR1020157029360 A KR 1020157029360A KR 20157029360 A KR20157029360 A KR 20157029360A KR 102221041 B1 KR102221041 B1 KR 102221041B1
Authority
KR
South Korea
Prior art keywords
angptl4
delete delete
leu
ala
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157029360A
Other languages
English (en)
Korean (ko)
Other versions
KR20150140686A (ko
Inventor
에스. 추프 수만트
Original Assignee
에스. 추프 수만트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/841,240 external-priority patent/US9139629B2/en
Application filed by 에스. 추프 수만트 filed Critical 에스. 추프 수만트
Publication of KR20150140686A publication Critical patent/KR20150140686A/ko
Application granted granted Critical
Publication of KR102221041B1 publication Critical patent/KR102221041B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020157029360A 2013-03-15 2014-03-15 신증후군 및 관련 병태의 치료 방법 Active KR102221041B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/841,240 2013-03-15
US13/841,240 US9139629B2 (en) 2010-06-05 2013-03-15 Methods for treatment of nephrotic syndrome and related conditions
PCT/US2014/030009 WO2014145275A1 (en) 2013-03-15 2014-03-15 Methods for treatment of nephrotic syndrome and related conditions

Publications (2)

Publication Number Publication Date
KR20150140686A KR20150140686A (ko) 2015-12-16
KR102221041B1 true KR102221041B1 (ko) 2021-02-25

Family

ID=51537930

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157029360A Active KR102221041B1 (ko) 2013-03-15 2014-03-15 신증후군 및 관련 병태의 치료 방법

Country Status (8)

Country Link
EP (1) EP2970416B1 (https=)
JP (1) JP2016516726A (https=)
KR (1) KR102221041B1 (https=)
CN (1) CN105229024A (https=)
AU (1) AU2014233219B2 (https=)
CA (3) CA2906982C (https=)
NZ (1) NZ712935A (https=)
WO (1) WO2014145275A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101706296B1 (ko) 2015-12-21 2017-02-13 주식회사 브레인온 기억력, 학습력, 인지력 향상용 조성물
US20180201645A1 (en) * 2015-12-21 2018-07-19 Brainon Inc. Composition for improving memory, learning ability, and cognitive ability
EP3803412A1 (en) 2018-06-01 2021-04-14 Laboratory Corporation of America Holdings Simplified biosample processing for lc-ms/ms
CN112292125B (zh) * 2018-06-22 2023-10-31 西奈克制药有限公司 蛋白尿的治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT1781698T (lt) * 2004-07-20 2016-09-26 Genentech, Inc. Į angiopoetiną panašaus baltymo 4 kompozicijos ir panaudojimo būdai
US9475850B2 (en) * 2010-06-05 2016-10-25 The Uab Research Foundation Methods for treatment of nephrotic syndrome and related conditions
EP3318269B1 (en) * 2010-06-05 2024-03-13 Chugh, Sumant S. Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.
US20110301103A1 (en) * 2010-06-05 2011-12-08 Chugh Sumant S Methods of Treatment

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Nature Medicine, Vol. 17, No. 1, pp.117-123 (2011. 1.)
PNAS Vol. 103m No. 46, pp.17450-17455 (2006. 11. 14.)
인용발명 : J. Biol. Chem., Vol. 284, No. 19, pp.13213-13222 (2009. 5. 8.).*

Also Published As

Publication number Publication date
KR20150140686A (ko) 2015-12-16
CA3152699C (en) 2023-09-05
CA2906982A1 (en) 2014-09-18
EP2970416A1 (en) 2016-01-20
WO2014145275A1 (en) 2014-09-18
CA3207108A1 (en) 2014-09-18
CN105229024A (zh) 2016-01-06
AU2014233219B2 (en) 2018-02-22
NZ712935A (en) 2020-03-27
HK1220213A1 (en) 2017-04-28
AU2014233219A1 (en) 2015-10-08
CA3152699A1 (en) 2014-09-18
JP2016516726A (ja) 2016-06-09
EP2970416B1 (en) 2023-11-22
EP2970416A4 (en) 2017-02-22
EP2970416C0 (en) 2023-11-22
CA2906982C (en) 2022-05-31

Similar Documents

Publication Publication Date Title
DK2575858T3 (en) METHOD OF TREATING NEPHROTIC SYNDROME AND RELATED DISEASES
KR102221041B1 (ko) 신증후군 및 관련 병태의 치료 방법
JP5231214B2 (ja) エリスロポエチン変異体
US11866468B2 (en) Methods for treatment of nephrotic syndrome and related conditions
US9475850B2 (en) Methods for treatment of nephrotic syndrome and related conditions
KR20180009382A (ko) 치료 방법
WO2022143938A1 (zh) 一种激活nk细胞的肿瘤免疫治疗方法
US20110312872A1 (en) Norrin in the treatment of diseases associated with an increased tgf-beta activity
KR20240013770A (ko) 신장 활성 융합 단백질 및 이를 사용하는 치료 방법
US20260124275A1 (en) Methods of treating diabetes and related complications
HK1220213B (en) Methods for treatment of nephrotic syndrome and related conditions
HK1252916B (en) Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20151014

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20160927

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190313

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200622

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210203

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210222

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210222

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240205

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20241230

Start annual number: 5

End annual number: 5